Cargando…

The role of magnetic resonance imaging in the evaluation of transfusional iron overload in myelodysplastic syndromes

Myelodysplastic syndromes represent a group of heterogeneous hematopoietic neoplasms derived from an abnormal multipotent progenitor cell, characterized by a hyperproliferative bone marrow, dysplasia of the cellular hemopoietic elements and ineffective erythropoiesis. Anemia is a common finding in m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Petrou, Emmanouil, Mavrogeni, Sophie, Karali, Vasiliki, Kolovou, Genovefa, Kyrtsonis, Marie-Christine, Sfikakis, Petros P., Panayiotidis, Panayiotis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Hematologia e Hemoterapia 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4519711/ https://www.ncbi.nlm.nih.gov/pubmed/26190429 http://dx.doi.org/10.1016/j.bjhh.2015.03.014

Ejemplares similares

Stress perfusion Cardiac Magnetic Resonance in Patients with Antiphospholipid Syndrome
por: Tektonidou, Maria G., et al.
Publicado: (2018)

Overview of guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload
por: Gattermann, Norbert
Publicado: (2008)

The Double-Edged Sword of T1-Mapping in Systemic Sclerosis—A Comparison with Infectious Myocarditis Using Cardiovascular Magnetic Resonance
por: Markousis-Mavrogenis, George, et al.
Publicado: (2020)

The emerging role of Cardiovascular Magnetic Resonance in the evaluation of hypertensive heart disease
por: Mavrogeni, Sophie, et al.
Publicado: (2017)

Cardiovascular Magnetic Resonance Reveals Cardiac Pathophysiology in Autoimmune Rheumatic Diseases
por: Markousis-Mavrogenis, George, et al.
Publicado: (2021)

Cardiovascular magnetic resonance imaging: clinical implications in the evaluation of connective tissue diseases
por: Mavrogeni, Sophie, et al.
Publicado: (2017)

Management of transfusional iron overload – differential properties and efficacy of iron chelating agents
por: Kwiatkowski, Janet L
Publicado: (2011)

Combined Brain-Heart Magnetic Resonance Imaging in Autoimmune Rheumatic Disease Patients with Cardiac Symptoms: Hypothesis Generating Insights from a Cross-Sectional Study
por: Markousis-Mavrogenis, George, et al.
Publicado: (2020)

Transfusional Iron Overload in a Cohort of Children with Sickle Cell Disease: Impact of Magnetic Resonance Imaging, Transfusion Method, and Chelation
por: Stanley, Helen M., et al.
Publicado: (2016)

In vivo calibration of the T2* cardiovascular magnetic resonance method at 1.5 T for estimation of cardiac iron in a minipig model of transfusional iron overload
por: Jensen, Peter Diedrich, et al.
Publicado: (2021)

Cardiovascular Magnetic Resonance Identifies High-Risk Systemic Sclerosis Patients with Normal Echocardiograms and Provides Incremental Prognostic Value
por: Markousis-Mavrogenis, George, et al.
Publicado: (2019)

Cardiovascular Magnetic Resonance as Pathophysiologic Tool in Diabetes Mellitus
por: Mavrogeni, Sophie I., et al.
Publicado: (2021)

Systemic lupus erythematosus with antiphospholipid syndrome: Cardiovascular magnetic resonance for evaluation of cardiac hypertrophy
por: Mavrogeni, Sophie I., et al.
Publicado: (2017)

Chelation Therapy with Oral Solution of Deferiprone in Transfusional Iron-Overloaded Children with Hemoglobinopathies
por: Makis, Alexandros, et al.
Publicado: (2013)

PB2565: TRANSFUSIONAL IRON OVERLOAD AND ASSOCIATED COMPLICATIONS IN HEMATOLOGY DISORDERS PATIENTS
por: Romanenko, Nikolay, et al.
Publicado: (2023)

HFE gene mutation and oxidative damage biomarkers in patients with myelodysplastic syndromes and its relation to transfusional iron overload: an observational cross-sectional study
por: De Souza, Geane Felix, et al.
Publicado: (2015)

Transfusional iron overload and intravenous iron infusions modify the mouse gut microbiota similarly to dietary iron
por: La Carpia, Francesca, et al.
Publicado: (2019)

Lipidomics in vascular health: current perspectives
por: Kolovou, Genovefa, et al.
Publicado: (2015)

Combined Brain/Heart Magnetic Resonance Imaging in Systemic Lupus Erythematosus
por: Mavrogeni, Sophie, et al.
Publicado: (2020)

We Are Ageing
por: Kolovou, Genovefa D., et al.
Publicado: (2014)

Cardiovascular Magnetic Resonance Detects Inflammatory Cardiomyopathy in Symptomatic Patients with Inflammatory Joint Diseases and a Normal Routine Workup
por: Markousis-Mavrogenis, George, et al.
Publicado: (2022)

A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease
por: Vichinsky, Elliott, et al.
Publicado: (2007)

Arrhythmogenic Inflammatory Cardiomyopathy in Autoimmune Rheumatic Diseases: A Challenge for Cardio-Rheumatology
por: Mavrogeni, Sophie I., et al.
Publicado: (2019)

The Sphinx’s riddle: cardiovascular involvement in autoimmune rheumatic disease
por: Mavrogeni, Sophie, et al.
Publicado: (2016)

Cardiovascular Magnetic Resonance Imaging Patterns in Rare Cardiovascular Diseases
por: Markousis-Mavrogenis, George, et al.
Publicado: (2022)

Prevalence and Management of Transfusional Iron Overload in Syrian Beta Thalassemia Major Patients Pre and during the Syrian Conflict
por: Touma, Hanan, et al.
Publicado: (2023)

Cardiovascular magnetic resonance clarifies arrhythmogenicity in asymptomatic young athletes with ventricular arrhythmias undergoing pre-participation evaluation
por: Markousis-Mavrogenis, George, et al.
Publicado: (2020)

Silent myocarditis in systemic sclerosis detected by cardiovascular magnetic resonance using Lake Louise criteria
por: Mavrogeni, Sophie, et al.
Publicado: (2017)

Ventricular Tachycardia Has Mainly Non-Ischaemic Substrates in Patients with Autoimmune Rheumatic Diseases and a Preserved Ejection Fraction
por: Markousis-Mavrogenis, George, et al.
Publicado: (2021)

Non-traumatic and non-drug-induced rhabdomyolysis
por: Kolovou, Genovefa, et al.
Publicado: (2019)

Deferiprone vs deferoxamine for transfusional iron overload in SCD and other anemias: a randomized, open-label noninferiority study
por: Kwiatkowski, Janet L., et al.
Publicado: (2022)

The safety and acceptability of twice‐daily deferiprone for transfusional iron overload: A multicentre, open‐label, phase 2 study
por: Badawy, Sherif M., et al.
Publicado: (2021)

Deferiprone for transfusional iron overload in sickle cell disease and other anemias: open-label study of up to 3 years
por: Elalfy, Mohsen S., et al.
Publicado: (2022)

Myocardial infarction as a thrombotic complication of myeloproliferative disorders
por: Petrou, Emmanouil, et al.
Publicado: (2016)

Five gene variants in nonagenarians, centenarians and average individuals
por: Kolovou, Vana, et al.
Publicado: (2017)

Cardiac magnetic resonance predicts ventricular arrhythmias in scleroderma: the Scleroderma Arrhythmia Clinical Utility Study (SAnCtUS)
por: Mavrogeni, Sophie, et al.
Publicado: (2020)

Long-term safety and efficacy of deferasirox (Exjade®) for up to 5 years in transfusional iron-overloaded patients with sickle cell disease
por: Vichinsky, Elliott, et al.
Publicado: (2011)

Xanthomas Regression in an 8-Year-Old Boy Treated With Lomitapide
por: Kolovou, Genovefa, et al.
Publicado: (2019)

Angiotensinogen (AGT) M235T, AGT T174M and Angiotensin-1-Converting Enzyme (ACE) I/D Gene Polymorphisms in Essential Hypertension: Effects on Ramipril Efficacy
por: Kolovou, Vana, et al.
Publicado: (2015)

Medicina transfusional
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_ucb1vt5htmgpkb52f0qi25ldpv